Literature DB >> 18853197

Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab.

Ajay P Sharma, Guido Filler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18853197     DOI： 10.1007/s00467-008-1030-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children.

Authors:  Guido Filler; Miriam Hansen; Claire LeBlanc; Nathalie Lepage; Doris Franke; Ingrid Mai; Janusz Feber
Journal:  Pediatr Nephrol       Date:  2003-04-08       Impact factor: 3.714

2.  Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab.

Authors:  Megha Suri; Kim Tran; Ajay P Sharma; Guido Filler; Joanne Grimmer
Journal:  Int Urol Nephrol       Date:  2008-05-20       Impact factor: 2.370

Review 3.  Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).

Authors:  A C Allison; E M Eugui
Journal:  Clin Transplant       Date:  1996-02       Impact factor: 2.863

4.  Rituximab for refractory focal segmental glomerulosclerosis.

Authors:  Makiko Nakayama; Koichi Kamei; Kandai Nozu; Kentaro Matsuoka; Atsuko Nakagawa; Mayumi Sako; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2007-11-01       Impact factor: 3.714

5.  Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.

Authors:  Vincent Guigonis; Aymeric Dallocchio; Véronique Baudouin; Maud Dehennault; Caroline Hachon-Le Camus; Mickael Afanetti; Jaap Groothoff; Brigitte Llanas; Patrick Niaudet; Hubert Nivet; Natacha Raynaud; Sophie Taque; Pierre Ronco; François Bouissou
Journal:  Pediatr Nephrol       Date:  2008-05-09       Impact factor: 3.714
  5 in total
  9 in total

Review 1.  Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children.

Authors:  Koichi Kamei; Kenji Ishikura; Mayumi Sako; Shuichi Ito; Kandai Nozu; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2018-12-18       Impact factor: 3.714

Review 2.  Childhood nephrotic syndrome--current and future therapies.

Authors:  Larry A Greenbaum; Rainer Benndorf; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2012-06-12       Impact factor: 28.314

3.  Should we consider MMF therapy after rituximab for nephrotic syndrome?

Authors:  Guido Filler; Shih-Han Susan Huang; Ajay P Sharma
Journal:  Pediatr Nephrol       Date:  2011-05-01       Impact factor: 3.714

4.  Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.

Authors:  Shuichiro Fujinaga; Daishi Hirano; Naoto Nishizaki; Koichi Kamei; Shuichi Ito; Yoshiyuki Ohtomo; Toshiaki Shimizu; Kazunari Kaneko
Journal:  Pediatr Nephrol       Date:  2010-01-05       Impact factor: 3.714

5.  Rituximab in refractory nephrotic syndrome.

Authors:  Agnieszka Prytuła; Kazumoto Iijima; Koichi Kamei; Denis Geary; Errol Gottlich; Abdul Majeed; Mark Taylor; Stephen D Marks; Shamir Tuchman; Roberta Camilla; Milos Ognjanovic; Guido Filler; Graham Smith; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2009-12-23       Impact factor: 3.714

6.  Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin.

Authors:  Hiroshi Kaito; Koichi Kamei; Eriko Kikuchi; Masao Ogura; Kentaro Matsuoka; Michio Nagata; Kazumoto Iijima; Shuichi Ito
Journal:  Pediatr Nephrol       Date:  2009-12-22       Impact factor: 3.714

7.  Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome.

Authors:  Shuichi Ito; Koichi Kamei; Masao Ogura; Mai Sato; Takuya Fujimaru; Tomoaki Ishikawa; Tomohiro Udagawa; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2011-05-10       Impact factor: 3.651

8.  Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome.

Authors:  Shuichi Ito; Koichi Kamei; Masao Ogura; Tomohiro Udagawa; Shuichiro Fujinaga; Mari Saito; Mayumi Sako; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2012-10-10       Impact factor: 3.651

9.  Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.

Authors:  Biswanath Basu; Stella Preussler; Anja Sander; T K S Mahapatra; Franz Schaefer
Journal:  BMC Nephrol       Date:  2020-11-30       Impact factor: 2.388
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.